ABSTRACT
PURPOSE: Assessment of the additional morbidity risk due to repeated bedside chest radiography according to ICRP 60 during intensive care. MATERIAL AND METHODS: Ventral surface doses were recorded by thermoluminescence dosimetry in 2 man and 7 women, mean age 36 +/- 12 years, mean height 169 +/- 5 cm, mean weight 74 +/- 8 kg, receiving long-term ventilation therapy due to Adult Respiratory Distress Syndrome (ARDS). RESULTS: From 18 to 126 days duration of therapy 9 patients received a total of 348 bedside chest radiographs, mean 39 +/- 22 radiographs per patient. 217 chest radiographs yielded 217 surface doses and 217 gonadal doses. Patient's mean surface dose varies between at least 0.31 +/- 0.12 mGy and at most 0.56 +/- 0.09 mGy. The surface dose representing gonadal exposure is less than 0.03 mGy per exposure. The mean effective dose is about 0.15 mSv per exposure. The cumulative effective dose Heff ranges between 2.49 mSv and 14.09 mSv, thus estimating the additional individual cancer risk ranges between 0.01% and 0.07%. CONCLUSION: In comparison with the decreased prognosis of severely ill long-term ventilated patients the additional morbidity risk due to chest radiographs is a negligible quantity.
